Cargando…
B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis
Cardiac involvement is a major mortality cause in eosinophilic granulomatosis with polyangiitis (EGPA), requiring novel therapeutics to spare the use of cyclophosphamide with known cardiotoxicity. Despite the observed efficacy of B-cell-depleting therapy in myocarditis of seropositive microscopic po...
Autores principales: | Wang, Chrong-Reen, Tsai, Yi-Shan, Tsai, Hung-Wen, Lee, Cheng-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509673/ https://www.ncbi.nlm.nih.gov/pubmed/34640595 http://dx.doi.org/10.3390/jcm10194577 |
Ejemplares similares
-
Mepolizumab therapy improves endomyocarditis in seropositive eosinophilic granulomatosis with polyangiitis
por: Wang, Chrong-Reen, et al.
Publicado: (2022) -
Seronegative spondyloarthropathy-associated inflammatory bowel disease
por: Wang, Chrong-Reen, et al.
Publicado: (2023) -
A case report of myocarditis secondary to eosinophilic granulomatosis with polyangiitis
por: Condurache, Dorina-Gabriela, et al.
Publicado: (2022) -
Eosinophilic Granulomatosis with Polyangiitis
por: Shukla, Ratnakar, et al.
Publicado: (2022) -
Eosinophilic myocarditis as a first presentation of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
por: Bluett, Ronan, et al.
Publicado: (2017)